Jean Schoenen
Université de Liège
H-index: 103
Europe-Belgium
Top articles of Jean Schoenen
Oxygen as an abortive therapy in cluster headache: a narrative review and clinical practice aspects
2024/3/18
Jean Schoenen
H-Index: 49
International Classification of Headache Disorders-4 – Work in Progress 1
2024/2
Jean Schoenen
H-Index: 49
Cristina Tassorelli
H-Index: 39
Exploring the Therapeutic Potential of Quadripulse rTMS over the Visual Cortex: A Proof-of-Concept Study in Healthy Volunteers and Chronic Migraine Patients with Medication …
Biomedicines
2024/1/26
Vittorio Di Piero
H-Index: 22
Jean Schoenen
H-Index: 49
Central sensitization mechanisms in chronic migraine with medication overuse headache: a study of thalamocortical activation and lateral cortical inhibition
Cephalalgia
2023/10
Jean Schoenen
H-Index: 49
Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review
2023/8/1
Jean Schoenen
H-Index: 49
Burden of migraine in patients attending Belgian headache specialists: real-world evidence from the BECOME study
Acta Neurologica Belgica
2023/8
Jean Schoenen
H-Index: 49
Reply to Dr. Jacome's letter
2023/7/3
Jean Schoenen
H-Index: 49
The longitudinal influence of tDCS on occipital GABA and glutamate/glutamine levels in episodic migraineurs
Journal of Neuroscience Research
2023/6
Jean Schoenen
H-Index: 49
Whole brain surface-based morphometry and tract-based spatial statistics in migraine with aura patients: difference between pure visual and complex auras
Frontiers in Human Neuroscience
2023/4/18
Jean Schoenen
H-Index: 49
Vittorio Di Piero
H-Index: 22
Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
Scientific reports
2023/3/7
Jean Schoenen
H-Index: 49
Re: Do we need a method to pre-operatively predict the efficacy of STS?
2023/3/6
Jean Schoenen
H-Index: 49
Jean Schoenen
H-Index: 49
Addendum to" Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial"
2023/2/24
Effects of botulinum toxin type A on the nociceptive and lemniscal somatosensory systems in chronic migraine: An electrophysiological study
Toxins
2023/1/14
Francesco Pierelli
H-Index: 36
Jean Schoenen
H-Index: 49
Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment
Headache: The Journal of Head and Face Pain
2022/1
Jean Schoenen
H-Index: 49
Guidelines of the International Headache Society for controlled clinical trials in cluster headache
Cephalalgia
2023/8
Cluster Headache and the Comprehension Paradox
SN Comprehensive Clinical Medicine
2022/12
Jean Schoenen
H-Index: 49
Bimodal sensory integration in migraine: A study of the effect of visual stimulation on somatosensory evoked cortical responses
Cephalalgia
2022/6
Jean Schoenen
H-Index: 49
# MIGRAINE-TOO: News et fake news sur une maladie invisible
2022/1/12
Jean Schoenen
H-Index: 49
Erenumab for migraine prevention in a 1-year compassionate use program: efficacy, tolerability, and differences between clinical phenotypes
Frontiers in Neurology
2021/12/10
Jean Schoenen
H-Index: 49
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
The journal of headache and pain
2021/12
Jean Schoenen
H-Index: 49
